Principal Financial Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,190
| Closed | -$244K | – | 2323 |
|
|
2024
Q2 | $244K | Sell |
8,190
-3,908
| -32% | -$117K | ﹤0.01% | 2100 |
|
|
2024
Q1 | $486K | Buy |
12,098
+547
| +5% | +$22K | ﹤0.01% | 1989 |
|
|
2023
Q4 | $294K | Sell |
11,551
-32
| -0.3% | -$815 | ﹤0.01% | 2071 |
|
|
2023
Q3 | $161K | Sell |
11,583
-145
| -1% | -$2.02K | ﹤0.01% | 2199 |
|
|
2023
Q2 | $270K | Sell |
11,728
-651
| -5% | -$15K | ﹤0.01% | 2100 |
|
|
2023
Q1 | $367K | Buy |
12,379
+1,533
| +14% | +$45.4K | ﹤0.01% | 2043 |
|
|
2022
Q4 | $271K | Buy |
10,846
+967
| +10% | +$24.1K | ﹤0.01% | 2129 |
|
|
2022
Q3 | $215K | Buy |
+9,879
| New | +$215K | ﹤0.01% | 2188 |
|
|
2022
Q2 | – | Sell |
-12,048
| Closed | -$510K | – | 2586 |
|
|
2022
Q1 | $510K | Buy |
12,048
+71
| +0.6% | +$3.01K | ﹤0.01% | 2113 |
|
|
2021
Q4 | $760K | Buy |
11,977
+4,767
| +66% | +$302K | ﹤0.01% | 2038 |
|
|
2021
Q3 | $424K | Buy |
7,210
+2,589
| +56% | +$152K | ﹤0.01% | 2214 |
|
|
2021
Q2 | $224K | Buy |
+4,621
| New | +$224K | ﹤0.01% | 2442 |
|